Ovid Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.741; its P/E ratio is -4.32; Ovid Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 141.56K	$ 108.97K	$ 75.00K	$ 66.16K	$ 1.50M
Gross Profit	$ 141.56K	$ 108.97K	$ 75.00K	$ 66.16K	$ 1.50M
EBIT	$ -15.32M	$ -11.25M	$ -12.41M	$ -13.36M	$ -11.55M
EBITDA	$ -14.92M	$ -10.85M	$ -12.01M	$ -12.96M	$ -11.11M
Net Income Common Stockholders	$ -15.32M	$ -11.25M	$ -12.41M	$ -13.36M	$ -11.50M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 105.83M	$ 87.07M	$ 96.52M	$ 117.72M	$ 129.00M
Total Assets	$ 144.03M	$ 125.03M	$ 136.23M	$ 143.37M	$ 155.27M
Total Debt	$ 16.00M	$ 16.30M	$ 16.33M	$ 16.50M	$ 16.54M
Net Debt	$ -89.83M	$ -70.77M	$ -80.18M	$ -101.22M	$ -112.47M
Total Liabilities	$ 56.23M	$ 23.74M	$ 25.53M	$ 22.42M	$ 22.99M
Stockholders Equity	$ 87.80M	$ 101.29M	$ 110.69M	$ 120.95M	$ 132.30M
Cash Flow	-
Free Cash Flow	$ -11.91M	$ -10.11M	$ -11.73M	$ -12.11M	$ -9.30M
Operating Cash Flow	$ -11.90M	$ -10.10M	$ -11.72M	$ -12.10M	$ -9.18M
Investing Cash Flow	$ -48.52M	$ -4.36M	$ 20.07M	$ 30.23M	$ -4.17M
Financing Cash Flow	$ 30.03M	$ 223.72K	$ 211.10K	$ 66.99K	$ -43.60K

Currency in USD

Ovid Therapeutics Earnings and Revenue History

Income Statement >

Ovid Therapeutics Debt to Assets

Balance Sheet >

Ovid Therapeutics Cash Flow

Cash Flow >

Ovid Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing